Sign In
Buy PLX
$1.96
-0.0300 (-1.51%)
At Close: Jun 03, 2026
Protalix BioTherapeutics to Announce Second Quarter 2022 Financial and Business Results Conference Call on August 15, 2022
06:50am, Monday, 08'th Aug 2022
Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel , Aug. 8, 2022 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical compan
Protalix BioTherapeutics, Inc. (PLX) CEO Dror Bashan on Q1 2022 Results - Earnings Call Transcript
09:48am, Monday, 16'th May 2022
Protalix BioTherapeutics Inc. (NYSE:PLX ) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Alexandra Schuman - LifeSci Advisors, IR Dror Bashan - President & CEO Eyal Rubi
Protalix Shares Surge After Encouraging Topline Data From Another Fabry Disease Trial
12:22pm, Monday, 04'th Apr 2022
Protalix BioTherapeutics Inc (NYSE: PLX) and Chiesi Global Rare Diseases, a unit of Chiesi Farmaceutici S.p.A., have announced topline data from the BALANCE Phase 3 trial evaluating pegunigalsida
Protalix BioTherapeutics (PLX) CEO, Dror Bashan on Q4 2021 Results - Earnings Call Transcript
10:41am, Thursday, 31'st Mar 2022
Protalix BioTherapeutics (PLX) CEO, Dror Bashan on Q4 2021 Results - Earnings Call Transcript
Protalix BioTherapeutics to Hold Fiscal Year 2021 Financial and Business Results Conference Call on March 31, 2022
06:50am, Thursday, 24'th Mar 2022
Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel, March 24, 2022 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical co
Protalix Bio, Chiesi Release Final Results From Late-Stage PRX-102 Trial In Fabry Disease
10:09am, Friday, 18'th Mar 2022
Protalix BioTherapeutics Inc (NYSE: PLX) and Chiesi Global Rare Diseases, a unit of Chiesi Farmaceutici S.p.A, have announced final results from the BRIGHT Phase 3 trial of pegunigalsidase alfa (P
Botanical and Plant-Derived Drugs Market to Grow by USD 15.89 bn | Technavio
04:00am, Tuesday, 01'st Mar 2022 Kwhen Finance
Protalix, Chiesi Global file for EU approval of PRX-102 for Fabry disease
01:01pm, Thursday, 24'th Feb 2022 Seeking Alpha
Protalix BioTherapeutics (PLX) and Chiesi Global Rare Diseases, a unit of Chiesi Farmaceutici S.p.A., submitted an application via centralized procedure to the European Medicines…
Protalix BioTherapeutics to Participate in the 18th Annual WORLDSymposium 2022
11:50am, Thursday, 03'rd Feb 2022 Kwhen Finance
Protalix Biotherapeutics: Is It Worth The Wait?
01:30pm, Friday, 07'th Jan 2022 Seeking AlphaProtalix Biotherapeutics: Is It Worth The Wait?
08:30am, Friday, 07'th Jan 2022
Protalix concluded its Type A meeting with the US Food and Drug Administration (FDA), providing a way forward with its lead indication PRX-102. Protalix published top line results of the interim analy
Have an attention on: PolarityTE, Inc. (NASDAQ:PTE), Protalix BioTherapeutics, Inc. (AMEX:PLX)
04:40am, Friday, 24'th Dec 2021 Stock Equity
PolarityTE, Inc. (NASDAQ:PTE) with the stream of 1.65% also noticed, India Protalix BioTherapeutics, Inc. (AMEX:PLX) encountered a rapid change of 5.26% in the last hour of Thursdays trading session. PolarityTE, The post Have an attention on: PolarityTE, Inc. (NASDAQ:PTE), Protalix BioTherapeutics, Inc. (AMEX:PLX) appeared first on Stocks Equity .
Small Cap Alert: ToughBuilt Industries, Inc. (NASDAQ:TBLT), Protalix BioTherapeutics, Inc. (AMEX:PLX)
10:38am, Wednesday, 22'nd Dec 2021 Stock Equity
ToughBuilt Industries, Inc. (NASDAQ:TBLT) with the stream of 2.99% also noticed, India Protalix BioTherapeutics, Inc. (AMEX:PLX) encountered a rapid change of 1.56% in the last hour of Tuesdays trading session. The post Small Cap Alert: ToughBuilt Industries, Inc. (NASDAQ:TBLT), Protalix BioTherapeutics, Inc. (AMEX:PLX) appeared first on Stocks Equity .
Best Penny Stocks To Buy? 5 Short Squeeze Stocks To Watch Right Now
03:05pm, Tuesday, 21'st Dec 2021
5 penny stocks with high short interest to add to your watch list in December. The post Best Penny Stocks To Buy?
Hottest Stock Now: Senmiao Technology Limited (NASDAQ:AIHS), Protalix BioTherapeutics, Inc. (AMEX:PLX)
01:11am, Monday, 13'th Dec 2021 Stock Equity
Senmiao Technology Limited (NASDAQ:AIHS) with the stream of -2.88% also noticed, India Protalix BioTherapeutics, Inc. (AMEX:PLX) encountered a rapid change of 1.11% in the last hour of Fridays trading session. The post Hottest Stock Now: Senmiao Technology Limited (NASDAQ:AIHS), Protalix BioTherapeutics, Inc. (AMEX:PLX) appeared first on Stocks Equity .
